#ScribeTherapeutics
LightNews LightNews
pharmaphorum.bsky.social
#ScribeTherapeutics has become the latest #biotech to announce plans to list on the #Nasdaq, in what is being seen as a test of the appetite among #investors for earlier-stage drug developers.
Scribe Therapeutics joins the IPO queue
Scribe Therapeutics has become the latest biotech to announce plans to list on the Nasdaq as it advances its spin on CRISPR-based therapeutics.
buff.ly
July 3, 2026 at 3:30 PM
nile11.bsky.social
Former Amazon Scientist’s Boson AI Launches Speech Model to Challenge OpenAI and Meta on Voice Costs
#a#aegisaia#alexSmolab#bosonAif#fulluplex #h#higgsRealtimeo#openais#scribeTherapeuticss#speecho-speech #t#temasekn#nile1
Former Amazon Scientist’s Boson AI Launches Speech Model to Challenge OpenAI and Meta on Voice Costs
Santa Clara-based startup Boson AI is preparing to roll out its debut speech-to-speech model, Higgs RealTime, targeting a major pain point in the
nile1.com
July 27, 2026 at 11:03 AM
pharmaphorum.bsky.social
#ScribeTherapeutics has become the latest #biotech to list on the #Nasdaq in the US, raising more than $155 million to advance a pipeline of in vivo #CRISPR-based therapies for #cardiometabolicdiseases.
Scribe raises $155m in IPO, as Apnimed pitches for $150m
Gene-editing specialist Scribe becomes the 14th biotech to list on the Nasdaq this year, as sleep apnoea drug developer Apnimed prices its listing.
buff.ly
July 28, 2026 at 11:30 AM
robot2trade.bsky.social
#$SCTX IPO Debut
Priced at $15 → Opened $25
Now +47.6% at $22.14
CRISPR gene-editing biotech! Strong first-day pop. NOT FINANCIAL ADVICE, DYOR! #SCTX #ScribeTherapeutics #IPO
July 24, 2026 at 5:52 PM
longevitytech.bsky.social
A second milestone for Scribe and Lilly highlights growing confidence in CRISPR as a tool for longer, healthier lives.

vist.ly/4svez

#longevity #GeneEditing #CRISPR #InVivo #BiotechInnovation #GenomicMedicine #HealthyAging #Lilly #ScribeTherapeutics
February 25, 2026 at 7:29 PM